BRAF and thyroid cancer: The results showed that CYP2S1 knockdown significantly inhibited cell proliferation in BRAFV600E-mutated thyroid cancer cell lines, but not in BRAF wild-type ones (Fig. 2b), also supported by colony formation assays (Fig. 2c).